Hobnail variant of papillary thyroid carcinoma: An institutional case series and molecular profile

Thyroid

Volumn 24, Issue 6, 2014, Pages 958-965

  Lubitz, Carrie C ^a   Economopoulos, Konstantinos P ^a   Pawlak, Amanda C ^a   Lynch, Kerry ^a   Dias Santagata, Dora ^a   Faquin, William C ^a   Sadow, Peter M ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RNA; B RAF KINASE; PROTEIN RET; RET PROTEIN, HUMAN;

ADULT; ANAPLASTIC CARCINOMA; ARTICLE; CANCER INCIDENCE; CLINICAL ARTICLE; DATA BASE; FEMALE; GENE MUTATION; GENE REARRANGEMENT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID CARCINOMA; THYROID PAPILLARY CARCINOMA; AGED; CARCINOMA; GENETICS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PATHOLOGY; PROGNOSIS; THYROID TUMOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; FEMALE; GENE REARRANGEMENT; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROTO-ONCOGENE PROTEINS B-RAF; PROTO-ONCOGENE PROTEINS C-RET; THYROID NEOPLASMS;

EID: 84902125749     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2013.0573     Document Type: Article

References (37)

1. 1. National Cancer Institute 2013 Fast stats: An interactive tool for access to SEER cancer statistics. Available at http://seer.cancer.gov/faststats (accessed on September 18, 2013).
2. Aschebrook-Kilfoy B, Ward MH, Sabra MM, Devesa SS 2011 Thyroid cancer incidence patterns in the United States by histologic type, 1992-2006. Thyroid 21:125-134.
3. Howlader N, Noone AM, Krapcho M, Garshell J, Neyman N, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds) SEER cancer statistics review, 1975-2010. Available at http://seer.cancer.gov/csr/1975-2010/(accessed August 20, 2013).
4. Prescott JD, Sadow PM, Hodin RA, Le LP, Gaz RD, Randolph GW, Stephen AE, Parangi S, Daniels GH, Lubitz CC 2012 BRAF V600E status adds incremental value to current risk classification systems in predicting papillary thyroid carcinoma recurrence. Surgery 152:984-990.
5. Hay ID, Thompson GB, Grant CS, Bergstralh EJ, Dvorak CE, Gorman CA, Maurer MS, McIver B, Mullan BP, Oberg AL, Powell CC, van Heerden JA, Goellner JR 2002 Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): Temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World J Surg 26:879-885. (Pubitemid 36920280)
6. Grogan RH, Kaplan SP, Cao H, Weiss RE, Degroot LJ, Simon CA, Embia OM, Angelos P, Kaplan EL, Schechter RB 2013A study of recurrence and death from papillary thyroid cancer with 27 years of median follow-up. Surgery 154:1436-1446.
7. Ortiz S, Rodriguez JM, Parrilla P, Perez D, Moreno-Gallego A, Rios A, Soria T 2001 Recurrent papillary thyroid cancer: Analysis of prognostic factors including the histological variant. Eur J Surg 167:406-412. (Pubitemid 32607814)
8. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM 2009 Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167-1214.
9. LiVolsi VA 2010 Papillary carcinoma tall cell variant (TCV): A review. Endocr Pathol 21:12-15.
10. Morris LG, Shaha AR, Tuttle RM, Sikora AG, Ganly I Tallcell variant of papillary thyroid carcinoma: A matched-pair analysis of survival. Thyroid 20:153-158.
11. Lin HW, Bhattacharyya N 2010 Clinical behavior of follicular variant of papillary thyroid carcinoma: Presentation and survival. Laryngoscope 120:712-716.
12. Asioli S, Erickson LA, Sebo TJ, Zhang J, Jin L, Thompson GB, Lloyd RV 2010 Papillary thyroid carcinoma with prominent hobnail features: A new aggressive variant of moderately differentiated papillary carcinoma. A clinicopathologic, immunohistochemical, and molecular study of eight cases. Am J Surg Pathol 34:44-52.
13. Motosugi U, Murata S, Nagata K, Yasuda M, Shimizu M 2009 Thyroid papillary carcinoma with micropapillary and hobnail growth pattern: A histological variant with intermediate malignancy Thyroid 19:535-537.
14. Lino-Silva LS, Dominguez-Malagon HR, Caro-Sanchez CH, Salcedo-Hernandez RA 2012 Thyroid gland papillary carcinomas with "micropapillary pattern," a recently recognized poor prognostic finding: Clinicopathologic and survival analysis of 7 cases. Hum Pathol 43:1596-1600.
15. Dias-Santagata D, Akhavanfard S, David SS, Vernovsky K, Kuhlmann G, Boisvert SL, Stubbs H, McDermott U, Settleman J, Kwak EL, Clark JW, Isakoff SJ, Sequist LV, Engelman JA, Lynch TJ, Haber DA, Louis DN, Ellisen LW, Borger DR, Iafrate AJ 2010 Rapid targeted mutational analysis of human tumours: A clinical platform to guide personalized cancer medicine. EMBO Mol Med 2:146-158.
16. Li C, Lee KC, Schneider EB, Zeiger MA 2012 BRAF V600E mutation and its association with clinicopathological features of papillary thyroid cancer: A meta-analysis. J Clin Endocrinol Metab 97:4559-4570.
17. Edge S, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (eds) 2009 AJCC Cancer Staging Manual. Springer, New York.
18. Nikiforov YE, Steward DL, Robinson-Smith TM, Haugen BR, Klopper JP, Zhu Z, Fagin JA, Falciglia M, Weber K, Nikiforova MN 2009 Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules. J Clin Endocrinol Metab 94:2092-2098.
19. Xing M, Alzahrani AS, Carson KA, Viola D, Elisei R, Bendlova B, Yip L, Mian C, Vianello F, Tuttle RM, Robenshtok E, Fagin JA, Puxeddu E, Fugazzola L, Czarniecka A, Jarzab B, O'Neill CJ, Sywak MS, Lam AK, Riesco-Eizaguirre G, Santisteban P, Nakayama H, Tufano RP, Pai SI, Zeiger MA, Westra WH, Clark DP, Clifton-Bligh R, Sidransky D, Ladenson PW, Sykorova V 2013 Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer. JAMA 309:1493-1501.
20. Guerra A, Sapio MR, Marotta V, Campanile E, Rossi S, Forno I, Fugazzola L, Budillon A, Moccia T, Fenzi G, Vitale M 2012 The primary occurrence of BRAF(V600E) is a rare clonal event in papillary thyroid carcinoma. J Clin Endocrinol Metab 97:517-524.
21. Romei C, Elisei R 2012 RET/PTC Translocations and clinico-pathological features in human papillary thyroid carcinoma. Front Endocrinol (Lausanne) 3:54.
22. Kakudo K, Tang W, Ito Y, Mori I, Nakamura Y, Miyauchi A 2004 Papillary carcinoma of the thyroid in Japan: Subclassification of common type and identification of low risk group. J Clin Pathol 57:1041-1046. (Pubitemid 39331353)
23. Albores-Saavedra J, Wu J 2006 The many faces and mimics of papillary thyroid carcinoma. Endocr Pathol 17:1-18. (Pubitemid 43997969)
24. Liu Z, Bai Y, Li Y, Ohba K, Nakamura H, Ozaki T, Taniguchi E, Mori I, Kakudo K 2010 Non-solid type thyroid carcinoma: A case report of moderately differentiated adenocarcinoma of the thyroid. Pathol Int 60:524-527.
25. Liu Z, Kakudo K, Bai Y, Li Y, Ozaki T, Miyauchi A, Taniguchi E, Mori I 2011 Loss of cellular polarity/cohesiveness in the invasive front of papillary thyroid carcinoma, a novel predictor for lymph node metastasis; possible morphological indicator of epithelial mesenchymal transition. J Clin Pathol 64:325-329.
26. Bai Y, Kakudo K, Nakamura M, Ozaki T, Li Y, Liu Z, Mori I, Miyauchi A, Zhou G 2009 Loss of cellular polarity/cohesiveness in the invasive front of papillary thyroid carcinoma and periostin expression. Cancer Lett 281:188-195.
27. Bai Y, Kakudo K, Li Y, Liu Z, Ozaki T, Ito Y, Kihara M, Miyauchi A 2008 Subclassification of non-solid-type papillary thyroid carcinoma identification of high-risk group in common type. Cancer Sci 99:1908-1915.
28. Tang W, Nakamura Y, Zuo H, Yasuoka H, Yang Q, Wang X, Nakamura M, Mori I, Miyauchi A, Kakudo K 2003 Differentiation, proliferation and retinoid receptor status of papillary carcinoma of the thyroid. Pathol Int 53:204-213. (Pubitemid 36628227)
29. Asioli S, Erickson LA, Righi A, Lloyd RV 2012 Papillary thyroid carcinoma with hobnail features: Histopathologic criteria to predict aggressive behavior. Hum Pathol 44:320-328.
30. Yang GC, Fried K, Scognamiglio T 2013 Cytological features of clear cell thyroid tumors, including a papillary thyroid carcinoma with prominent hobnail features. Diagn Cytopathol 41:757-761.
31. Yu XM, Schneider DF, Leverson G, Chen H, Sippel RS 2013 Follicular variant of papillary thyroid carcinoma is a unique clinical entity: A population-based study of 10,740 cases. Thyroid 23:1263-1268.
32. Morris LG, Shaha AR, Tuttle RM, Sikora AG, Ganly I 2010 Tall-cell variant of papillary thyroid carcinoma: A matched-pair analysis of survival. Thyroid 20:153-158.
33. Chen L, Fan Y, Lang RG, Guo XJ, Sun YL, Cui LF, Liu FF, Wei J, Zhang XM, Fu L 2008 Breast carcinoma with micropapillary features: Clinicopathologic study and longterm follow-up of 100 cases. Int J Surg Pathol 16:155-163. (Pubitemid 351549762)
34. Chang SJ, Ryu HS, Chang KH, Yoo SC, Yoon JH 2008 Prognostic significance of the micropapillary pattern in patients with serous borderline ovarian tumors. Acta Obstet Gynecol Scand 87:476-481.
35. Sanchez-Mora N, Presmanes MC, Monroy V, Moreno N, Lara-Martinez JM, Aladro MH, Alvarez-Fernandez E 2008 Micropapillary lung adenocarcinoma: A distinctive histologic subtype with prognostic significance. Case series. Hum Pathol 39:324-330. (Pubitemid 351186688)
36. Amin MB, Ro JY, El-Sharkawy T, Lee KM, Troncoso P, Silva EG, Ordonez NG, Ayala AG 1994 Micropapillary variant of transitional cell carcinoma of the urinary bladder. Histologic pattern resembling ovarian papillary serous carcinoma. Am J Surg Pathol 18:1224-1232. (Pubitemid 24362435)
37. Elisei R, Viola D, Torregrossa L, Giannini R, Romei C, Ugolini C, Molinaro E, Agate L, Biagini A, Lupi C, Valerio L, Materazzi G, Miccoli P, Piaggi P, Pinchera A, Vitti P, Basolo F 2012 The BRAF(V600E) mutation is an independent, poor prognostic factor for the outcome of patients with low-risk intrathyroid papillary thyroid carcinoma: Single-institution results from a large cohort study. J Clin Endocrinol Metab 97:4390-4398.